Smith Brendan 4
4 · CRISPR Therapeutics AG · Filed Aug 18, 2022
Insider Transaction Report
Form 4
Smith Brendan
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2022-08-16+10,000→ 10,000 total→ Common Shares (10,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
- [F2]The restricted stock units shall vest in full on February 16, 2025, subject to continued service to the Company or any of its subsidiaries.